Enhancing the potential of methotrexate.
Optimise rheumatism treatment in Finland with Metoject® PEN1 and ensure long-term success of therapy
Helsinki / Wedel (September 21, 2017). There is room for improvement in drug treatment of rheumatoid arthritis (RA) with the gold standard methotrexate (MTX). Current analyses of the FIN-ERA cohort suggest that Finnish rheumatology exploits the potential of methotrexate as initial treatment and follows the European treatment guidelines in a slightly adopted way focusing on combination therapy: “At baseline, 68 % used methotrexate-based combination therapy, and 31 % used triple therapy with methotrexate, hydroxychloroquine, and sulphasalazine (the Fin-RACo regimen)”.
Click here to view full Press release
High sat literature scores you deserve the sat subject tests are extremely beneficial for college bound students, they even pay someone to do homework have the ability to grant college credit in certain courses.